Results     17-May-24
Announcements
Zydus Lifesciences consolidated net profit rises 298.62% in the March 2024 quarter
Sales rise 10.59% to Rs 5366.40 crore
Net profit of Zydus Lifesciences rose 298.62% to Rs 1182.30 crore in the quarter ended March 2024 as against Rs 296.60 crore during the previous quarter ended March 2023. Sales rose 10.59% to Rs 5366.40 crore in the quarter ended March 2024 as against Rs 4852.50 crore during the previous quarter ended March 2023.

For the full year,net profit rose 96.88% to Rs 3859.50 crore in the year ended March 2024 as against Rs 1960.30 crore during the previous year ended March 2023. Sales rose 12.70% to Rs 19021.50 crore in the year ended March 2024 as against Rs 16877.80 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales5366.404852.50 11 19021.5016877.80 13
OPM %30.3825.88 -28.3122.87 -
PBDT1752.301265.70 38 5587.203916.60 43
PBT1547.001087.10 42 4823.103193.90 51
NP1182.30296.60 299 3859.501960.30 97

Previous News
  Zydus receives USFDA final approval for Cyclophosphamide Capsules
 ( Corporate News - 14-Dec-23   18:57 )
  Zydus Life Vadodara unit gets OAI report from USFDA
 ( Hot Pursuit - 19-Jul-24   09:49 )
  Zydus Life gets US FDA nod for anti-cancer medication Cyclophosphamide
 ( Hot Pursuit - 14-Dec-23   14:31 )
  Zydus partners with Lupin to market Saroglitazar Mg in India
 ( Corporate News - 03-Nov-23   14:46 )
  Zydus Lifesciences Ltd rises for third consecutive session
 ( Hot Pursuit - 27-Jun-23   13:05 )
  Zydus Lifesciences appoints Punit Patel as Chief Executive Officer - Americas
 ( Corporate News - 16-Oct-23   10:24 )
  Zydus Lifesciences Ltd soars 1.52%, rises for fifth straight session
 ( Hot Pursuit - 11-Mar-24   13:00 )
  Zydus Lifesciences Ltd spurts 0.94%, up for five straight sessions
 ( Hot Pursuit - 16-Jun-23   13:00 )
  Zydus Life gets USFDA nod for Vigabatrin oral solution
 ( Hot Pursuit - 06-Mar-23   10:26 )
  Zydus Lifesciences receives USFDA approval for Tadalafil Tablets
 ( Corporate News - 07-Jun-23   15:45 )
  Zydus receives USFDA approval for Metoprolol Tartrate Tablets
 ( Corporate News - 20-Apr-23   13:26 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top